Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide.
D007516:Adenoma, Islet Cell / Q000139:chemically induced / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors*; D004110:Diltiazem / Q000494:pharmacology; D005934:Glucagon / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism; D009536:Niacinamide; D010190:Pancreatic Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D051381:Rats; D013311:Streptozocin
D007328:Insulin; D009536:Niacinamide; D013311:Streptozocin; D005934:Glucagon; D004110:Diltiazem; D005947:Glucose; D002118:Calcium